How much debt does Mineralys Therapeutics have?

According to Mineralys Therapeutics's latest annual financial reports, the company's debt profile is as follows:

Total Debt and Liabilities

Mineralys Therapeutics's total debt stands at $-. This is broken down into:

• Long-term debt: $-
• Short-term debt: $-

The company's net debt, which accounts for cash and cash equivalents, is $-114.09M. In terms of overall financial obligations, Mineralys Therapeutics's total liabilities amount to $14.65M.

Debt Ratios and Metrics

To better understand Mineralys Therapeutics's debt position, we can look at several key ratios:

• Debt to Equity Ratio: 0.00 - this indicates the proportion of equity and debt the company uses to finance its assets.
• Debt Ratio: 0.00% - this shows the proportion of a company's assets that are financed through debt.
• Interest Coverage Ratio: 0.00 - this measures how easily a company can pay interest on its outstanding debt.
• Long-term Debt to Capitalization: 0.00% - this shows the proportion of long-term debt in the company's capital structure.
• Total Debt to Capitalization: 0.00% - this indicates the total debt in the company's capital structure.

These metrics provide insight into Mineralys Therapeutics's financial leverage and its ability to meet financial obligations. For a comprehensive understanding of the company's financial health, it's important to consider these debt metrics alongside other financial indicators and industry benchmarks.